SEC Form 4 · accession 0001104659-15-043830
Hepion Pharmaceuticals, Inc. · HEPA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Sapirstein
Officer — Chief Executive Officer · Director
Period of report
Jun 4, 2015
Accepted (ET)
Jun 8, 2015 · 8:29 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583771
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $3.60 | Jun 4, 2015 | A | 150,000 | A | — | Jun 4, 2025 | Common Stock | 150,000 | 1,650,000 | D |
Explanation of responses
- F1Options vest in three installments as follows: 50,000 options shall vest on each of June 4, 2016, 2017 and 2018.